Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07759128
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety DisorderOtsuka Pharmaceutical Development & Commercialization, Inc.RecruitingPhase 3
NCT07759128Recruiting
Phase 3
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With G...Otsuka Pharmaceutical Dev...
NCT07760467
To Evaluate Safety, Tolerability, PK/PD & Food Effect of Single/Multiple Oral TUL321 Capsules in Healthy Participants.Zhuhai United Laboratories Co., Ltd.Not Yet RecruitingPhase 1
NCT07760467Not Yet Recruiting
Phase 1
To Evaluate Safety, Tolerability, PK/PD & Food Effect of Single/Multiple Oral TU...Zhuhai United Laboratorie...
NCT07761858
AI-Powered Beauty Perceptions and Social Media Awareness Regarding Appearance on Social Appearance Anxiety in Patients Undergoing Cosmetic SurgeryAydin Adnan Menderes UniversityActive Not Recruiting
NCT07761858Active Not Recruiting
—
AI-Powered Beauty Perceptions and Social Media Awareness Regarding Appearance on...Aydin Adnan Menderes Univ...
NCT07760714
A Real-World Study of Treatment Patterns, Tolerability and Effectiveness of CDK4/6 Inhibition in HR+, HER2-negative Metastatic Breast Cancer PatientsNovartis PharmaceuticalsCompleted
NCT07760714Completed
—
A Real-World Study of Treatment Patterns, Tolerability and Effectiveness of CDK4...Novartis Pharmaceuticals
NCT07759479
Effects of the Rebozo Technique During Active Labor on Labor Pain and Labor Duration in Primiparous WomenIstanbul UniversityCompletedNot Applicable
NCT07759479Completed
Not Applicable
Effects of the Rebozo Technique During Active Labor on Labor Pain and Labor Dura...Istanbul University
NCT07761572
CS1 Added to Standard of Care Therapy for Pulmonary Arterial HypertensionCereno Scientific ABNot Yet RecruitingPhase 2
NCT07761572Not Yet Recruiting
Phase 2
CS1 Added to Standard of Care Therapy for Pulmonary Arterial HypertensionCereno Scientific AB
NCT07759115
Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility StudyNational Institute of Nursing Research (NINR)Not Yet RecruitingNot Applicable
NCT07759115Not Yet Recruiting
Not Applicable
Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feas...National Institute of Nur...
NCT07759349
Comparison Of Acetaminophen, NSAIDs, And Trypsin-Chymotrypsin Plus Acetaminophen For Post-Endodontic Pain After Single-Visit Root Canal TreatmentDow University of Health SciencesRecruitingEarly Phase 1
NCT07759349Recruiting
Early Phase 1
Comparison Of Acetaminophen, NSAIDs, And Trypsin-Chymotrypsin Plus Acetaminophen...Dow University of Health...
NCT07761832
Hemoglobin Trends as a Predictor of Outcomes in Critically Ill Patients (The TRENT-ICU Study)Hospital H+ QueretaroCompleted
NCT07761832Completed
—
Hemoglobin Trends as a Predictor of Outcomes in Critically Ill Patients (The TRE...Hospital H+ Queretaro
NCT07759622
The Cesarean Study: Optimizing Cesarean Sections and Improving Patient-Healthcare Provider Trust Using Evidence Informed RecommendationsLund UniversityRecruitingNot Applicable
NCT07759622Recruiting
Not Applicable
The Cesarean Study: Optimizing Cesarean Sections and Improving Patient-Healthcar...Lund University
NCT07759895
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in SchizophreniaAmit LotanNot Yet RecruitingPhase 2
NCT07759895Not Yet Recruiting
Phase 2
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Sy...Amit Lotan
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07759375
Combined Intervention Program for Non-fluent Aphasia Based on NeuroplasticityUniversidad de GranadaNot Yet RecruitingNot Applicable
NCT07759375Not Yet Recruiting
Not Applicable
Combined Intervention Program for Non-fluent Aphasia Based on NeuroplasticityUniversidad de Granada
NCT07761650
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital LahoreCompletedNot Applicable
NCT07761650Completed
Not Applicable
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital Lahore
NCT07761325
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for Prevention of CINV in Breast Cancer Patients Receiving Highly Emetogenic ChemotherapySun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 3
NCT07761325Not Yet Recruiting
Phase 3
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone...Sun Yat-Sen Memorial Hosp...
NCT07760350
Assessing the Feasibility of the "Heart Care Pairs" InterventionNational Institute on Minority Health and Health Disparities (NIMHD)Not Yet RecruitingNot Applicable
NCT07760350Not Yet Recruiting
Not Applicable
Assessing the Feasibility of the "Heart Care Pairs" InterventionNational Institute on Min...
NCT07760779
Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and Brief MindfulnessNational Institute on Aging (NIA)Not Yet RecruitingNot Applicable
NCT07760779Not Yet Recruiting
Not Applicable
Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and B...National Institute on Agi...
NCT07761871
Exercise and Nutritional Intervention in Patients With Melanoma Receiving ImmunotherapyInstitute of Oncology LjubljanaRecruitingNot Applicable
NCT07761871Recruiting
Not Applicable
Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immuno...Institute of Oncology Lju...
NCT07759687
Lion's Mane Dosing on Attention and MoodNorthumbria UniversityNot Yet RecruitingNot Applicable
NCT07759687Not Yet Recruiting
Not Applicable
Lion's Mane Dosing on Attention and MoodNorthumbria University
Result Breakdown
Not yet recruiting10 (50%)
Recruiting5 (25%)
Completed4 (20%)
Active, not recruiting1 (5%)
not_applicable11 (55%)
Not Specified3 (15%)
Phase 32 (10%)
Phase 22 (10%)
Phase 11 (5%)
Early Phase 11 (5%)